$Pfizer(PFE)$
$Pfizer Inc.(PFE) Gains 1.48%: Dividend Giant Bounces from Support, Facing Analyst Downgrade Pressure
Latest Close Data ๐
Closed at $24.07 on 2026-07-08, up +1.48% ($0.35). Still 16.3% below its 52-week high of $28.75.
Core Market Drivers โ๏ธ
-
Key oncology drug Sigvotatug Vedotin failed its Phase 3 trial (OS endpoint), pressuring the pipeline. ๐งช
-
HSBC downgraded PFE to "Hold" from "Buy" and cut its price target to $28 from $32, citing pipeline concerns. ๐
-
The company maintained its quarterly dividend at $0.43/share (yield ~7.14%), providing income support. ๐ฐ
Technical Analysis ๐
Volume was 44.1M shares (Volume Ratio 0.82), below average, indicating a lack of strong conviction in the bounce. RSI(6) at 43.07 is neutral, recovering from oversold levels but not yet bullish. MACD remains in negative territory (latest -0.145), though the histogram shows a slight reduction in bearish momentum. Overall, signals suggest a tentative stabilization, not a strong reversal.
Key Price Levels ๐ฏ
-
Primary Support: $23.86 (recent low, held on 07-07). A break below targets the 52-week low of $23.11.
-
Strong Resistance: $26.12 (recent high from 07-07). This is the key level to watch for a trend change.
-
Immediate Pivot: $24.07 (today's close). Sustaining above here is needed for further recovery.
Valuation Perspective ๐งฎ
Forward P/E is 8.01, significantly below its historical average of 10.38 and near the -1 Std. Dev. of 7.36, suggesting the market has priced in significant pessimism. P/S TTM is 2.16.
Analyst Targets ๐ฏ
Covered by 29 analysts with an average target price of $28.89 (approx. +20% upside). Consensus leans "Hold" (19 analysts), with 5 Strong Buy and 6 Buy ratings.
Weekly Outlook ๐ฎ
Expect consolidation between $23.86 and $25.00 in the near term. A decisive break above $25 could retest $26.12 resistance. Failure to hold $23.86 may lead to a test of the $23.11 yearly low. The high dividend yield may limit downside volatility.
Risk Disclaimer โ ๏ธ
This content is for informational purposes only and not investment advice. Past performance does not guarantee future results. Investing involves risk, including potential loss of principal. Always conduct your own research and consider consulting a financial advisor.
Comments